American Society of Hematology

The Hematologist: ASH News and Reports, the Society's member newsletter, is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.

A Resounding Success: Inaugural Lymphoma Biology Meeting

Dr. Linda J. Burns reviews ASH's first meeting covering the latest lymphoma science.

Read more

Is the NIH Expert Report on Sickle Cell Disease a “Clinical Practice Guideline We Can Trust?”

Dr. Alexis Thompson makes a thorough assessment of the latest clinical practice guidelines for sickle cell disease.

Read more
View All

Presidents Column

Dr_ Linda Burns

Linda J. Burns, MD

Professor of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis
A Resounding Success: Inaugural Lymphoma Biology Meeting
October 22, 2014

Dr. Burns recaps the first lymphoma biology meeting.

View All

Clinical Trials Corner

Perioperative Management of Patients on the New Oral Anticoagulants
October 23, 2014

Dr. Garcia examines the usefulness of new oral anticoagulants.

View All

Ask The Hematologist

Ask the Hematologist: A Diagnostic Approach to Patients with an IgM monoclonal protein
September 15, 2014

Dr. Mikhael discusses his approach to the evaluation of patients with an IgM monoclonal protein.

View All

Mini Review

Progress in the Diagnosis and Management of Type 1 von Willebrand Disease
November 18, 2014

Drs. Jonathan Roberts, Robert Montgomery, and Gilbert C. White review recent progress in diagnosing and managing von Willebrand Disease.

View All

Op Ed

Is the NIH Expert Report on Sickle Cell Disease a “Clinical Practice Guideline We Can Trust?”
November 19, 2014

Dr. Alexis Thompson makes a thorough assessment of the latest clinical practice guidelines for sickle cell disease.

View All
  • Institute of Medicine’s National Cancer Policy Forum Holds a Workshop on Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer

    ASH staff recently attended an IOM National Cancer Policy Forum workshop on policy issues in the development and adoption of molecularly targeted therapies for cancer.  The purpose of this workshop was to examine the recent trends in the development and implementation of molecularly targeted cancer therapies, address current challenges in the field, and to put forth potential strategies and policy action items that could improve current processes.


  • 2014 ASH Advocacy Efforts Related to Sickle Cell Disease

    ASH remains committed to working with various groups in the sickle cell stakeholder community, Congress, the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and other federal agencies to increase research, treatment options, and access to care for patients with sickle cell disease and sickle cell trait.  Continue reading about the major initiatives undertaken by the Society in 2014.

  • 2014 ASH Advocacy Efforts to Ensure Access to Safe and Effective Hematologic Drugs

    Over the past several years, shortages of drugs and biologics used to treat patients with hematologic diseases, including leukemia and lymphoma, have become critical and life-threatening.  ASH has taken a number of steps to resolve these drug and biologic shortages, including working with manufacturers, the Food & Drug Administration (FDA) and Congress.  ASH continues to be actively involved in this issue.  Continue reading for a summary of recent ASH advocacy efforts to address drug and biologic shortages.

  • 2014 NIH Funding Advocacy Highlights

    During 2014, ASH has continued to be one of the most visible advocates for federal support of biomedical research and funding for the National Institutes of Health (NIH).  Continue reading for a summary of ASH's 2014 advocacy efforts.

View all policy news
  • This Week in Blood: May 8, 2014

    Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD. If you would like a PDF copy of any of the manuscripts highlighted below or would like to request an interview with the author, please email aszabo@hematology.org.

  • This Week in Blood: April 24, 2014

    Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD. If you would like a PDF copy of any of the manuscripts highlighted below or would like to request an interview with the author, please email aszabo@hematology.org.

  • This Week in Blood: April 17, 2014

    Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD. If you would like a PDF copy of any of the manuscripts highlighted below or would like to request an interview with the author, please email aszabo@hematology.org.

  • This Week in Blood: April 10, 2014

    Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD. If you would like a PDF copy of any of the manuscripts highlighted below or would like to request an interview with the author, please email aszabo@hematology.org.

View all This Week in Blood
back to top